Curtis Health Caps provides soft gelatin capsules, non-sterile liquid products, and research and development (R&D) services for the pharmaceutical sector.
Curtis Health Caps is a multinational contract development and manufacturing organisation (CDMO) specialising in soft gelatin capsules, non-sterile liquid products, and research and development (R&D) services.
We offer a comprehensive range of solutions, from R&D services and regulatory audits to quality consultancy, production, storage and transport, all carefully tailored to the ever-changing needs of the market. Our services are in high demand from pharmaceutical contract manufacturing companies.
We operate a modern and innovative machinery park in Poland that features a well-equipped R&D department, employing experts across a range of fields. Professional support for pharmaceutical product development
As a CDMO, Curtis Health Caps provides clients with high-quality service throughout the whole product development process, from initial concept to final product.
Our experienced team can offer professional support with formulation and choosing the most suitable packaging. This allows you to easily add to your portfolio and find new pharmaceutical products for in-licensing.
Other services we offer include portfolio analysis, product licensing, dossier audits and regulatory support. Soft gelatin capsule development to client specifications
As part of the contractual production of medicinal products and food supplements, Curtis Health Caps allows clients to individually select the colour and shape of soft capsules to suit their specific requirements and preferences.
Soft gelatin capsules allow active pharmaceutical ingredients (APIs) to be absorbed quickly, with the gelatin shell guaranteeing airtight packaging for the ingredients in the capsule fill and protecting them against the effects of external factors.
The encapsulation process’ specificity ensures the product keeps its microbiological safety without the use of preservatives, which is particularly important in products intended for children. In addition, the capsule shell is made from biodegradable and environmentally friendly components. Development of pharmaceutical products in non-sterile liquid forms
Curtis Health Caps specialises in contract manufacturing medicinal products, food supplements and medical devices, as well as liquid forms of syrups, suspensions, drops and sprays. We can manufacture non-sterile liquid syrups, suspensions, drops or sprays according to clients’ preferences and customer needs.
Liquid-form products offer a wide dosage spectrum and have high absorption rates. They do not pose a risk of choking and are easier to swallow, making them more suitable to administer to children and elderly patients.
Our reliable personnel and technological resources ensure the quality of our services. Research and development services for pharmaceutical projects
Curtis Health Caps provides R&D services at all stages of development for capsules and non-sterile liquid products, from initial concept to finished product.
We help clients develop new product formulations to match market trends and consumer needs, as well as offering assistance for the development and modification of existing products. Our team can also carry out microbiological tests of raw materials and medicinal products in-line with pharmaceutical requirements.
Our R&D experts can assist with the development and validation of analytical methods for products; the development, validation or implementation of analytical methods for raw materials; and the optimisation of analytical procedures.
All these works are conducted according to International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines, pharmacopoeial requirements, and good manufacturing practice (GMP) standards. Manufacturing technology for pharmaceutical products
Curtis Health Caps offers a wide range of services for manufacturing soft gelatin capsules and non-sterile liquid forms. These include developing formulations for new products based on the latest market trends and literature, modifying existing product formulations, selecting raw materials of adequate quality from certified suppliers, and developing technology for trial and pilot batches. Regulatory compliance checks for product development
Curtis Health Caps provides regulatory audits for a range of medicinal products and medical devices.
We can assess products, devices and API manufacturing sites for compliance with different standards, including GMP and International Organisation for Standardisation (ISO) requirements. We also offer GMP services and training.
Our manufacturing facility in Przeźmierowo, Poland, is certified as complying with the EU’s GMP standards and the eighth edition of the UK’s Brand Reputation Compliance (BRC) Global Standards. We also hold ISO 9001:2015, 14001:2015 and 13485:2016 certifications.
A modern technology park and a number of qualified specialists guarantee that Curtis Health Caps provides the service of contract production of soft capsules at the highest level.
Curtis Health Caps specialises in the contract manufacturing of medicinal products, dietary supplements and medical devices in a liquid form of syrups, suspensions, drops and sprays.
We offer support in the selection process of a proper packaging mode, adjusted to a product specific and dosage as well as responding customer’s preferences and regulatory requirements.
We are a global CDMO (Contract Development & Manufacturing Organization) with over 30 years’ market experience.
We offer research and development services at all stages of the production of capsules, from idea to finished product for medicinal products, medical devices, food supplements, cosmetics and veterinary products.
Curtis Health Caps provides soft gelatin capsules and non-sterile liquid products, in addition to research and development (R&D) services.
Studies in pregnant women across the US, Northern Europe and the Middle East have shown that 26 90% of them are deficient in vitamin D, defined as a concentration of the vitamin D metabolite calcidiol (25(OH)D3) below 20 ng/ml.
Vitamin D administration is a therapeutic option in the management of a number of skin conditions.
Maintaining adequate vitamin D levels has also been shown to be important in autoimmune diseases, including autoimmune thyroid disease (AITD). Recently, many studies have shown a correlation between low vitamin D levels and Graves’ disease (GD) and chronic autoimmune thyroiditis/Hashimoto thyroiditis (HT).
SARS-CoV-2, responsible for the COVID-19 pandemics, has brought about an explosion of interest both in the mechanisms of infection, as well as in potential risk factors of the disease. Vitamin D has become a factor that may be involved in both these areas.
Curtis Health Caps addressing the key needs of consumers enriched its portfolio in melatonin in easy-to-apply oral spray.
Cognitive health is extremely important in the era of the ongoing COVID-19 pandemic – it has shown, among others, that more than half of the people experienced an increase in stress and insomnia during the pandemic.
Thank you for submitting the form. Your enquiry will be submitted to the company.
Thank you for subscribing to Pharmaceutical Technology